ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,844, issued on Jan. 20, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).
"Pharmaceutical formulations" was invented by Tommy Sander (Smoerum, Denmark), Christian Poulsen (Koebenhavn, Denmark) and Rosa Rebecca Erritzoee Hansen (Koebenhavn, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are an aqueous pharmaceutical formulation comprising cagrilintide and an aqueous formulation comprising semaglutide. The compositions of these two pharmaceutical formulations allow for their presentation in, and administration using, the dual-chamber medical device disclosed herein. Individuals with diseases, such as diabetes and/or obesi...